300049 logo

Inner Mongolia Furui Medical Science Co., Ltd. Stock Price

SZSE:300049 Community·CN¥18.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300049 Share Price Performance

CN¥69.80
33.89 (94.37%)
CN¥69.80
33.89 (94.37%)
Price CN¥69.80

300049 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with high growth potential.

1 Risk
1 Reward

Inner Mongolia Furui Medical Science Co., Ltd. Key Details

CN¥1.5b

Revenue

CN¥392.9m

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥954.1m

Other Expenses

CN¥123.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.46
73.28%
8.38%
0%
View Full Analysis

About 300049

Founded
1998
Employees
867
CEO
Guanyi Wang
WebsiteView website
www.fu-rui.com

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments; and FibroMeter series of blood test analysis tools for evaluating chronic liver disease. It provides digital health management services; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.

Recent 300049 News & Updates

Recent updates

No updates